Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)
Journal of the American Heart Association · 19.12.2023 · 12 (24)
DOI: 10.1161/jaha.123.031855 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 19.12.2023. Verfasst von Sem A O F Rikken und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology St. Antonius Hospital Nieuwegein The Netherlands. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Thrombocytopenia. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 platelets/μL), to severe (20 000 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology St. Antonius Hospital Nieuwegein The Netherlands.
- Cardiovascular Research Institute Maastricht (CARIM) Maastricht The Netherlands.
- Department of Cardiology MUMC+ Maastricht The Netherlands.
- Department of Cardiology Zuyderland Medical Centre Heerlen The Netherlands.
- The Christ Hospital Heart and Vascular Institute and Lindner Clinical Research Center Cincinnati OH USA.
- Allen and Frances Adler Laboratory of Blood and Vascular Biology Rockefeller University New York NY USA.
ORCID-Profile: Sem A O F Rikken, Arnoud W J van 't Hof, Jurriën M Ten Berg, Dean J Kereiakes, Barry S Coller
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Rikken, S. A. O. F., van 't Hof, A. W. J., Ten Berg, J. M., Kereiakes, D. J., & Coller, B. S. (2023). Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s). Journal of the American Heart Association, 12(24). https://doi.org/10.1161/jaha.123.031855
Vancouver
Rikken SAOF, van 't Hof AWJ, Ten Berg JM, Kereiakes DJ, Coller BS. Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s). Journal of the American Heart Association. 2023;12(24). doi:10.1161/jaha.123.031855
BibTeX
@article{Rikken2023,
author = {Rikken, Sem A O F and van 't Hof, Arnoud W J and Ten Berg, Jurriën M and Kereiakes, Dean J and Coller, Barry S},
title = {Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {24},
doi = {10.1161/jaha.123.031855}
}
EUVIMED